KP Journal of Clinical and Medical Case Reports

Review Article

Promising Role of FMT in Schizophrenia Therapeutics

Pushkala K1 and Gupta PD2*

1Former, Associate Professor, S. D. N. B. Vaishnav College for Women, Chennai, India

2Former Director Grade Scientist, Centre for Cellular and Molecular Biology, Hyderabad, India

Received: September 19, 2024; Published: October 11, 2024

*Corresponding author: Gupta PD, Former Director Grade Scientist, Centre for Cellular and Molecular Biology, Hyderabad,

Copyright: © 2024 Gupta PD, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

DOI: 10.71205/KPJCMCR/1010

Abstract

Schizophrenia is the resultant of the cumulative effect of a complex and dynamic bidirectional interaction of genetic expression and the accumulation of prenatal and postnatal environmental risk factors. Earlier treatments for schizophrenia include cognitive behavioral therapy (CBT), which can help people learn how to avoid acting on their thoughts. FMT is likely to strongly improve the efficacy of microbiota-orientated treatments. FMT is a promising treatment for schizophrenia and other psychiatric disorders that may help improve symptoms and restore behavioral impairments: FMT helps to restore the recipient’s gut microbiota and reverse dysbiosis. Current FMT is still a relatively new area of research, and there are several limitations to the current evidence

Keywords

Neurodevelopmental Disorder, Cognitive Behavioral Therapy, Antipsychotics.

Citation: Pushkala K, et al. © (2024). Promising Role of FMT in Schizophrenia Therapeutics. KP J Clin Med Case Rep. 2024; 3(1):1010